Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Blog | Veristat Insightful Perspectives

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Posts about

Clinical Trial Regulations (4)

Ensuring Patient Safety and Data Integrity with Veristat’s DMC Expertise

Data Monitoring Committees (DMCs) play a vital role in clinical trials by providing independent...

Bayesian Study Designs in Early-Phase Oncology Trials

The development of innovative oncology therapies has evolved dramatically, moving beyond...

Monthly FDA Guidance and Regulatory News Review - April 2025

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...

Staying the Course: What FDA Staffing Reductions Mean for Drug Development Today

The U.S. Food and Drug Administration (FDA) is undergoing significant change. Recent announcements...

Unlocking the Promise of Radiopharmaceuticals: Safety, Strategy & Innovation in Clinical Trials

We’re hearing more and more about the value of radiopharmaceuticals in medicine today—but what does...

Building Confidence in RWE: Delivering Smarter Regulatory Strategies

Real-world evidence (RWE) offers the potential to serve as a valuable tool in regulatory...

The Evolving Landscape of Radiopharmaceuticals in Oncology Research

Radiopharmaceuticals have been around for decades, but their role in oncology is expanding rapidly....

Monthly FDA Guidance and Regulatory News Review - March 2025

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...

Data Analysis Excellence: The Backbone of Successful Marketing Applications

In the complex landscape of marketing application preparation, data analysis stands as a critical...

Veristat Expands Global Regulatory Expertise

Meet Daphne Smyth, Vice President, Global Head of Regulatory Affairs